報價延遲最少15分鐘:2025/06/04 12:15 EDT
|
|
|
|
|
||||||||||||
|
|
|
|
|
14.185 
|
|
|
| 價值評估 |
|
盈利(現時/預測)
-3.82/-3.75
|
|
企業價值
447.47M
|
| 資產負債 |
|
每股賬面淨值
7.83
|
| 現金流量 |
|
現金流量率
--
|
| 損益表 |
|
收益
0
|
|
每股收益
--
|
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
報價延遲最少15分鐘：2025/06/04 12:15 EDT
同行比較之報價最少15分鐘延遲
|
業務概覽
|
|||
| Rapport Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovery and development of transformational small-molecule medicines for patients suffering from central nervous system disorders. Its foundational sciencehas elucidated the complexities of neuronal receptor biology and enables the company to map and target certain neuronal receptor complexes. Neuronal receptors are complex assemblies of proteins, comprising receptor principal subunits and their receptor-associated proteins (RAPs), the latter of which play crucial roles in regulating receptor expression and function. |